3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Medullary
9
Lung Neoplasms
8
Thyroid Neoplasms
7
Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pleural Effusion
2
Kidney Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Familial medullary thyroid carcinoma
2
Fallopian Tube Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid cancer, medullary
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Precancerous Conditions
1
Peritoneal Neoplasms
1
Oligodendroglioma
1
Multiple Endocrine Neoplasia Type 2b
1
Multiple Endocrine Neoplasia Type 2a
1
Interventions
Rituximab
9
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
fludarabine phosphate
6
Cyclophosphamide
6
Etoposide
5
Tacrolimus
4
Mycophenolic Acid
4
Cyclosporine
4
Carboplatin
4
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Busulfan
3
Thiotepa
2
Melphalan
2
Lenalidomide
2
Ipilimumab
2
Dexamethasone
2
Calcium Dobesilate
2
CTLA-4 Antigen
2
Bendamustine Hydrochloride
2
Antilymphocyte Serum
2
veliparib
1
sodium thiosulfate
1
pegfilgrastim
1
oblimersen
1
merphos
1
etoposide phosphate
1
Vorinostat
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Intraocular Lymphoma
×
vandetanib
×
Clear all
No trials found.